Focus on Cancer
by ReachMD
July 12, 2018 2:00 pm
According to the American Cancer Society, yearly deaths from cancer are decreasing— marking the first period of decline in nearly 70 years. ReachMD takes a closer look at the driving forces behind these advances: medications that hone in on specific tumor targets, more accurate screening and diagnostic technologies, and pioneering surgical methods that provide new hope for patients suffering from these devastating diseases.
Recent Episodes
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
6 years agoFDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
7 years agoCAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
7 years agoPancreatic Cancer: The Hunt to Catch a Silent Killer
7 years agoFDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
7 years agoFDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
7 years agoThe CAM Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing
7 years agoLinking p53 Variation to Breast Cancer Risk in African American Women
7 years agoFDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
7 years agoThe Financial Burden of Cancer: Report from the American Cancer Society
7 years ago